# Catch-up HPV vaccination for men to prevent throat cancer

Source: https://onco.cc/ideas/idea-prev-hpv-male-catchup-oropharynx/  
OnCo record `idea-prev-hpv-male-catchup-oropharynx` (Idea). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

HPV throat cancer now exceeds cervical cancer in some countries and mostly affects men, who were not vaccinated. Vaccinating men up to 45 could reduce it.

## Summary

HPV throat cancer now exceeds cervical cancer in some countries and mostly affects men who were never vaccinated, so this idea offers catch-up HPV vaccination to men up to age 45. HPV vaccination reduces oral HPV16 prevalence, oropharyngeal cancer incidence in men is rising, and the vaccine is safe in adults; the causal chain is strong despite the long latency. Oral HPV prevalence would serve as the intermediate endpoint with modelled cancer reduction. The test is prevalence surveys, modelling and cost-effectiveness analysis. Speculative in maturity, it addresses the bottleneck Prevention we already have is not deployed and links to HPV vaccination and head and neck cancer.

## Fields

- Kind: Idea
- Last checked: 2026-09-08
- Hypothesis: Catch-up vaccination of men aged 27-45 reduces oral HPV16 prevalence by at least half in the vaccinated and oropharyngeal cancer incidence by at least 20% within 20 years.
- Rationale: Long latency but a strong causal chain, and the vaccine is safe in adults.
- Proposed test: Prevalence surveys, modelling, and cost-effectiveness analysis.
- Maturity: speculative
- Actor: policy

## Sources

- Bottleneck evidence (Prevention we already have is not deployed): Islami et al., Proportion of cancer attributable to modifiable risk factors (CA 2018): https://doi.org/10.3322/caac.21440

## Connected records

- cancers: [Head and neck squamous cell carcinoma](https://onco.cc/cancers/head-and-neck/), [HPV-positive oropharyngeal cancer](https://onco.cc/cancers/hpv-positive-oropharyngeal-cancer/)
- fronts: [Prevention & Risk](https://onco.cc/fronts/prevention/)
- technologies: [HPV & HBV vaccination](https://onco.cc/technologies/hpv-vaccine/)
- bottlenecks: [Prevention we already have is not deployed](https://onco.cc/bottlenecks/b-prevention-adoption/)
- key papers: [England's HPV programme: cervical cancer down 87% in the first cohort vaccinated at 12-13](https://onco.cc/key-papers/paper-hpv-vaccine-england-lancet-2021/), [Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States](https://onco.cc/key-papers/paper-islami-ca-cancer-j-clin/)
- roadmaps: [Cancer prevention roadmap: tobacco control and vaccines → biomarker-guided chemoprevention → interception in carriers](https://onco.cc/roadmaps/prevention-roadmap/)

---
JSON: https://onco.cc/api/v1/entities/idea-prev-hpv-male-catchup-oropharynx.json